These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7007281)

  • 21. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240
    [No Abstract]   [Full Text] [Related]  

  • 23. [The antithrombotic treatment and prevention of recurrence with acetylsalicylic acid in myocardial infarct].
    Heuchel G; Hässler W
    Z Gesamte Inn Med; 1976 Feb; 31(3):61-5. PubMed ID: 1085534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acetylsalicylic acid after myocardial infarct].
    Sinzinger H; Kritz H
    Wien Klin Wochenschr; 1997; 109 Suppl 2():25-8. PubMed ID: 9340919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on secondary prevention of myocardial infarct (EPSIM). Work of the EPSIM research group].
    Arch Mal Coeur Vaiss; 1982 Dec; 75 Spec No():1-130. PubMed ID: 6820624
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antiplatelet agents--problem for cardiac surgeon].
    Bochenek A; Wilczyński M
    Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
    [No Abstract]   [Full Text] [Related]  

  • 27. Myocardial infarction.
    Prentice CR
    Clin Haematol; 1981 Jun; 10(2):521-41. PubMed ID: 7032787
    [No Abstract]   [Full Text] [Related]  

  • 28. [Secondary prevention following myocardial infarct. Which drug treatment is safe today?].
    Bungeroth KA
    Fortschr Med; 1987 Oct; 105(31):607-11. PubMed ID: 2891595
    [No Abstract]   [Full Text] [Related]  

  • 29. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 30. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interference in platelet-fibrinogen system for prevention and therapy of myocardial infarct].
    van de Loo J
    Dtsch Med Wochenschr; 1982 Jan; 107(2):66-70. PubMed ID: 7035118
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention and therapy with anticoagulants. Indications, experiences, results].
    Bruhn HD
    Intensivmed Prax; 1979; (2):91-7. PubMed ID: 553881
    [No Abstract]   [Full Text] [Related]  

  • 33. [Secondary prevention with drugs].
    Burkart F
    Schweiz Rundsch Med Prax; 1986 Jan; 75(4):57-60. PubMed ID: 2869563
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug therapy as secondary prevention following myocardial infarction].
    Cottier C
    Praxis (Bern 1994); 1996 Apr; 85(17):545-7. PubMed ID: 8668892
    [No Abstract]   [Full Text] [Related]  

  • 36. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
    Morrison CM; Gainsborough N; Rajkumar C
    Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anticoagulant or antiaggregant therapy in the secondary prevention of myocardial infarct?].
    De Caterina R; Gianetti J; Simonetti I; Gensini G
    G Ital Cardiol; 1996 Nov; 26(11):1309-21. PubMed ID: 9036028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of prevention of second myocardial infarct with syncumar or aspirin].
    Kraska T; Malanowicz W; Skarzyńska M; Tymińska K
    Kardiol Pol; 1981; 24(9):593-7. PubMed ID: 7029110
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin or warfarin: what's best after a heart attack? Risk of bleeding counters warfarin's edge in efficacy.
    Ornato JP
    Health News; 2002 Nov; 8(11):3. PubMed ID: 12523247
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of a high-dose parenteral thrombocyte aggregation inhibitors in recent myocardial infarct. Case contribution].
    Röhrer H; Groh R
    Med Welt; 1980 Dec; 31(51-52):1864-9. PubMed ID: 7464537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.